Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02615912 · ClinicalTrials.gov registry record · NA
A Single-Center, Exploratory Study to Analyze the Dynamics of Skin Microflora Following Exposure to Surfactants
A NA study, sponsored by Kimberly-Clark Corporation.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT02615912: Completed NA study, sponsored by Kimberly-Clark Corporation.
NCT02615912 is a NA study that has completed, run by Kimberly-Clark Corporation. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02615912, a NA study, has completed, sponsored by Kimberly-Clark Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to understand the changes in skin microflora, skin barrier function, and skin biochemical constituents in response to direct contact with model surfactants used in personal care articles. The results from this study will provide insights into the complex interaction between the skin microbiome and the epidermis after exposure to surfactants.
Primary Outcome
Microbes will be identified by metagenomic sequencing
Interventions
- OTHER PEG-40 Hydrogenated Castor Oil (Tagat CH40, Evonik) 1.5%
- OTHER Lauryl glucoside (Plantacare® 1200UP, BASF) 1.5%
- OTHER Sorbitan palmitate (SPANTM 40 (powder), Croda) 1.5%
- OTHER Silwet* DA-63 (Momentive) 1.5%
- OTHER Sodium lauryl sulfate (Sigma Aldrich) 1.0%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2015-11 |
| Est. Completion | 2016-02 |
| Phase | NA |
What the finished NCT02615912 record still lists
NCT02615912 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 5 interventions - of which PEG-40 Hydrogenated Castor Oil (Tagat CH40, Evonik) 1.5% is the first listed.
NCT02615912 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02615912 about?
NCT02615912 is a clinical study titled "A Single-Center, Exploratory Study to Analyze the Dynamics of Skin Microflora Following Exposure to Surfactants". The purpose of this study is to understand the changes in skin microflora, skin barrier function, and skin biochemical constituents in response to direct contact with model surfactants used in personal care articles. The results from this study will provide insights into the complex interaction betw...
What is the current status of trial NCT02615912?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2015-11. Estimated completion is 2016-02.
What interventions are being tested in trial NCT02615912?
The interventions under investigation include: PEG-40 Hydrogenated Castor Oil (Tagat CH40, Evonik) 1.5% (OTHER), Lauryl glucoside (Plantacare® 1200UP, BASF) 1.5% (OTHER), Sorbitan palmitate (SPANTM 40 (powder), Croda) 1.5% (OTHER), Silwet* DA-63 (Momentive) 1.5% (OTHER), Sodium lauryl sulfate (Sigma Aldrich) 1.0% (OTHER).
Who is sponsoring clinical trial NCT02615912?
This trial is sponsored by Kimberly-Clark Corporation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02615912's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia